LMR Partners’s Loxo Oncology, Inc LOXO Stock Holding History

LMR Partners’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-59,551	Closed	-$4.78M	–	645
2017 Q2	$4.78M	Buy	+59,551	New	+$3.3M	0.3%	56

Other funds holding LOXO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

LMR Partners's LOXO Position: Q3 2017 in Review

LMR Partners sold out of Loxo Oncology, Inc (LOXO) in Q3 2017, closing a stake of 59,551 shares — an estimated $4.78M sold.

LMR Partners first reported a position in LOXO in Q2 2017 and held it in 1 quarter. The position peaked at $4.78M in Q2 2017. 148 funds tracked by Wall St. Rank hold LOXO as of Q3 2017.

LMR Partners reported no remaining Loxo Oncology, Inc position as of Q3 2017 after selling out during the quarter.
LMR Partners sold 59,551 Loxo Oncology, Inc shares in Q3 2017, an estimated $4.78M.
LMR Partners first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 1 quarter.
LMR Partners's Loxo Oncology, Inc position peaked at $4.78M in Q2 2017.
148 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2017.

Based on LMR Partners's 13F filing for Q3 2017, filed 9 Nov 2017.